You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Delta-like protein 3 (DLL3)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Small Cell Lung Cancer Trial (Rovalpituzumab tesirine)

Completed
Has Results
  • Small Cell Lung Cancer
  • Rovalpituzumab tesirine
  • (no location specified)
Jul 28, 2021

Serum Insulin-like Growth Factor Binding Protein-3 asPotential

Not yet recruiting
  • Colorectal Cancer
  • evaluation of diagnostic importance of insulin like growth factor binding protein3 in patient with recently diagnosed as Colorectal cancer
  • (no location specified)
May 6, 2023

Neurofilament Light Chain ,Chitinase-3 Like-1 Proteins and

Not yet recruiting
  • Multiple Sclerosis
  • Neurofilament Light Chain ,Chitinase-3 Like-1 Protein Levels and Tolerogenic plasmacytoid Dendritic Cells
  • (no location specified)
Oct 10, 2022

Polycystic Ovary Syndrome Trial (SGLT2 inhibitors combined with metformin, Placebo combined with metformin)

Not yet recruiting
  • Polycystic Ovary Syndrome
  • SGLT2 inhibitors combined with metformin
  • Placebo combined with metformin
  • (no location specified)
Jul 21, 2023

B Acute Lymphoblastic Leukemia Trial (procedure, biological, drug, radiation)

Not yet recruiting
  • B Acute Lymphoblastic Leukemia
  • Biospecimen Collection
  • +19 more
  • (no location specified)
Nov 8, 2023

Neuroendocrine Prostate Cancer Trial in Worldwide (Tarlatamab)

Recruiting
  • Neuroendocrine Prostate Cancer
  • Phoenix, Arizona
  • +19 more
Aug 11, 2022

Muscle Protein Synthesis, Muscle Atrophy, Insulin Sensitivity Trial in Montréal (ketone monoester (R)-3-hydroxybutyl (R)-3-

Recruiting
  • Muscle Protein Synthesis
  • +7 more
  • ketone monoester (R)-3-hydroxybutyl (R)-3- hydroxybutyrate
  • carbohydrate-fat placebo (fructose, corn and canola oil 50:50 ratio)
  • MontrĂ©al, Quebec, Canada
    Research Institute - McGill University Health Centre
Jan 21, 2023

Myotonic Dystrophy Type 1 Trial in United States (rhIGF-I/rhIGFBP-3, )

Completed
Has Results
  • Myotonic Dystrophy Type 1
  • Orange, California
  • +11 more
Dec 8, 2021

Small Cell Lung Carcinoma Trial in Worldwide (AMG 757, Pembrolizumab, CRS Mitigation Strategies)

Recruiting
  • Small Cell Lung Carcinoma
  • AMG 757
  • +2 more
  • Duarte, California
  • +34 more
Dec 6, 2022

Malaria, Malaria,Falciparum, Parasitic Disease Trial in Oxford (RH5.1 and/or RH5.2-VLP with Matrix-M)

Not yet recruiting
  • Malaria
  • +4 more
  • RH5.1 and/or RH5.2-VLP with Matrix-M
  • Oxford, Oxfordshire, United Kingdom
    Centre for Clinical Vaccinology & Tropical Medicine (CCVTM)
Jul 27, 2023

Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia, Recurrent Mixed Phenotype Acute Leukemia

Not yet recruiting
  • Recurrent Acute Leukemia of Ambiguous Lineage
  • +5 more
  • Biospecimen Collection
  • +12 more
  • (no location specified)
Mar 8, 2023

Small-cell Lung Cancer Trial in United States (HPN328)

Recruiting
  • Small-cell Lung Cancer
  • Aurora, Colorado
  • +9 more
Jan 11, 2022

Small Cell Lung Cancer Trial in Worldwide (Rovalpituzumab tesirine, Topotecan, Dexamethasone)

Completed
Has Results
  • Small Cell Lung Cancer
  • Rovalpituzumab tesirine
  • +2 more
  • Huntsville, Alabama
  • +194 more
Feb 19, 2021

B Acute Lymphoblastic Leukemia, Ph-Like Acute Lymphoblastic Leukemia Trial in Duarte (Cyclophosphamide, Cytarabine, Daunorubicin

Recruiting
  • B Acute Lymphoblastic Leukemia
  • Ph-Like Acute Lymphoblastic Leukemia
  • Duarte, California
    City of Hope Medical Center
Jul 26, 2022

Recurrent B Acute Lymphoblastic Leukemia, Recurrent Ph-Like Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic

Terminated
Has Results
  • Recurrent B Acute Lymphoblastic Leukemia
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Apr 28, 2022

Stage III Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8, Stage IIIB Hepatocellular Carcinoma

Recruiting
  • Stage III Hepatocellular Carcinoma AJCC v8
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 18, 2021

Blastic Plasmacytoid Dendritic Cell Tumor Trial in Houston (Cyclophosphamide, Cytarabine, Dexamethasone)

Recruiting
  • Blastic Plasmacytoid Dendritic Cell Neoplasm
  • Houston, Texas
    M D Anderson Cancer Center
Nov 30, 2021

Small Cell Lung Cancer Trial in Tampa, Houston (AMG 119)

Suspended
  • Small Cell Lung Cancer
  • AMG 119
  • Tampa, Florida
  • +1 more
Nov 29, 2021

Malignant Melanoma, Medullary Thyroid Cancer, Glioblastoma Trial in United States (Rovalpituzumab tesirine, Dexamethasone)

Terminated
Has Results
  • Malignant Melanoma
  • +7 more
  • Gilbert, Arizona
  • +29 more
Sep 21, 2020

Glioma Trial (BI 764532)

Not yet recruiting
  • Glioma
  • BI 764532
  • (no location specified)
Jun 15, 2023

COVID-19 Trial (High dose of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell), Low dose of Recombinant

Not yet recruiting
  • COVID-19
  • High dose of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell)
  • +3 more
  • (no location specified)
Jun 19, 2023

Coronavirus Trial in Wuhu (Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells), Recombinant

Active, not recruiting
  • Coronavirus
  • Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells)
  • Recombinant novel coronavirus protein vaccine (CHO cells)
  • Wuhu, Anhui, China
    Wannan Medical College Yijishan Hospital
May 6, 2023

COVID-19 Trial (Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells), Placebo)

Not yet recruiting
  • COVID-19
  • Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells)
  • Placebo
  • (no location specified)
Sep 22, 2023

Extensive Stage Small Cell Lung Cancer Trial (Tarlatamab, Carboplatin, Etoposide)

Recruiting
  • Extensive Stage Small Cell Lung Cancer
  • Los Angeles, California
  • +37 more
Feb 1, 2023

COVID-19, Coronavirus Infections Trial in Halifax, Ottawa, Quebec (VBI-2901e)

Not yet recruiting
  • COVID-19
  • Coronavirus Infections
  • VBI-2901e
  • Halifax, Nova Scotia, Canada
  • +3 more
Dec 10, 2022